ultiple sclerosis (MS) is a chronic inflammatory, demyelinizing autoimmune illness which affects the central nervous system. The illness emerges with sudden symptoms related to vision and other senses, or, partial or complete paralysis. Perioperative stress, emotional instability, anesthesia and increased body temperature may aggravate MS attacks.
The Use of Rocuronium and Sugammadex on a Patient with Multiple Sclerosis
A AB BS ST TR RA AC CT T Multiple sclerosis (MS) is a chronic inflammatory, demyelinizing autoimmune illness which affects the central nervous system. Stress, surgery, anesthesia, emotional distress, changes in body temperature may lead to an increase in MS symptoms or new attacks in patients in remission.
One of the difficulties in the management of anesthesia seen in MS patients is the inability to reverse neuromuscular block early and completely. A 31-year-old female patient (74 kg, 169 cm) who consulted to the general surgery department with abdominal pain was admitted with the diagnosis of cholelithiasis and cholecystectomy was planned. This patient has been diagnosed as MS the age of 19, occasionally had attacks for 12 years and receives interferon-1a treatment. In this case report, a MS patient was presented who underwent laparoscopic cholecystectomy in which muscle relaxation was provided with rocuronium, and whose neuromuscular block was reversed with sugammadex. 
CASE REPORT
A 31-year-old female patient (74 kg, 169 cm) who was consulted to the general surgery department with abdominal pain was admitted with the diagnosis of cholelithiasis. In her past history, 12 years ago she was admitted to the neurology ward with the complaint of inability to walk, she was diagnosed as MS, and interferon-1a treatment was given 3 days a week. The patient stated that she had a final attack with a visual loss 4 months ago.
Preoperative neurological examination of the patient revealed sensory loss in the right lower and upper extremities. There were no motor deficits in the patient who specified floating specks occasionally. Deep tendon reflexes were recorded as normal. In the preoperative evaluation, the body temperature was 36.4°C, pulse rate was 76/min, blood pressure was 120/65 mmHg and the body weight was 74 kg. Total blood count, liver and kidney function tests, electrolytes, hemorrhage and coagulation time values were within normal limits in the patient. No abnormal pathology was found on electrocardiography (ECG), and no abnormal findings were seen on chest X-ray.
Before the surgery, information about the surgery, anesthesia, perioperative risks and management plans were given to the patient and written approval was taken. Diazepam 5 mg was given orally the night before the operation. One hour before the surgery, 2 mg of midazolam was administered intravenously. Non-invasive blood pressure, ECG, pulse oximetry (SpO2), and body temperature with esophageal temperature probe were monitored during the procedure. Neuromuscular activity via the TOF watch machine (TOF watchOrganon technical, Ireland) placed on the right arm. In addition, the depth of anesthesia was monitored with bispectral index (BIS) (NASAQ: MASI, Irvine CA).
Anesthesia induction was performed with propofol 200 mg, fentanyl 75 mcg and rocuronium 25 mg. After 2 minutes of ventilation with the mask, the patient was intubated when the TOF value was found to be 0. Maintenance of anesthesia was achieved with a mixture of 1-1,5% sevoflurane in O2/N2O (1: 1 ratio 3 l/min). An additional fentanyl 50 mcg was added before the surgical incision. Intraoperative BIS values and body temperature were kept stable at 32-50 and 35.8-36.2°C. No additional dose of rocuronium was needed during the surgery. TOF values did not exceed 0,4. For postoperative analgesia, tramadol 100 mg was given iv. while the surgical incision was closed. Ondansetron 5 mg was given again iv. to prevent vomiting and nausea. The operation lasted 95 minutes. One minute after the anesthetic gases were stopped, while the TOF value was 0,5, sugammadex 200 mg was administered iv. After 42 seconds, when the TOF value was observed to be 0,9, the patient was extubated. The patient who had relaxed spontaneous breathing was taken to the recovery room. The patient was observed for an hour in there. No complications were observed during the intraoperative or postoperative periods. No residual block was observed. The patient was hospitalized for two days and was discharged without any problems. In the one month follow-up, no additional pathology was observed in the patient related to MS.
DISCUSSION
Stress, surgery, anesthesia, emotional distress, changes in body temperature may lead to an increase in MS symptoms or new attacks in a patient in remission. For that reason, a good premedication, deep anesthesia, and postoperative pain control are very important before the anesthesia. 4 The disease predominantly affects women between 10-60 years old and is most commonly seen between 20-40 years old. 5 This patient has been diagnosed with MS at the age of 19, occasionally has had attacks for 12 years and receives interferon-1a treatment. The literature on the most optimal general anesthesia method in MS is generally limited to the case reports. It is reported that general anesthesia and surgical stress may cause exacerbation of MS as well as cases in which no attack is observed in postoperative follow-up. 3, 5, 6 One of the points to be considered in MS patients is to maintain the body temperature in a stable manner. It is known that the increase in the body temperature causes transmission block in demyelinated axons. 7, 8 In this case, the body temperature is closely monitored and ranged between 35.8-36.2°C.
While there are reports of safety of sevoflurane in maintenance of general anesthesia, no reports are found about desflurane use in the literature. For that reason, we also preferred to use sevoflurane as an inhalation agent on our patient. 9 The use of neuromuscular blocker drugs requires attention in MS patients. The upregulation of nicotinic acetylcholine receptors of skeletal muscles in MS patients was recorded. In addition to that, the anatomical alteration of receptor subunits causes to the extension of the channeling time. The dose, that is given due to the unforeseen response to neuromuscular blocker drugs, must be carefully regulated. Therefore, muscle relaxation induced by rocuronium may be expected to be longer than the normal. Sevoflurane is also known to enhance rocuronium-induced neuromuscular blockade. 1 For that reason, we applied rocuronium in the patient under the normal adopted dose (0,5 mg/kg) and decided to use sugammadex which completely removes the effect by encapsulating rocuronium. Sugammadex does not cross the blood-brain barrier and does not affect the peripheral muscles through the central nervous system. In the case reported by Sinikoğlu et al. repeated use of sugammadex has been quick and successful at reversing the neuromuscular block each time. 1 The mean time needed to reach 1,0 TOF value after sugammadex injection in all surgeries was reported to vary between 85-140 sec. An increased number of postjunctional receptors explains the relative resistance to non-depolarizing NMBDs; muscular weakness and decreased muscle mass may be responsible for the cases of increased sensitivity. Because of the unpredictable response to these agents it is imperative to carefully titrate the dose administered. 4 Therefore, we have applied to our patient muscle relaxation with 25 mg of rocuronium. As well as that the use of lower dose of rocuronium might be the reason for quick reversal of a TOF value of 0.9 (42 vs 85-140 sec). It is reported that the postoperative residual block can be seen even if a single dose of nondepolarizing muscle relaxant is used in standard anesthesia and emphasized that the application of sugammadex provides the rapid return of block and prevents the residual block. 10, 11 It is seen in our MS patient that the block returned successfully with sugammadex, who had muscle relaxation with rocuronium. No residual block was seen the postoperative period.
CONCLUSION
The use of rocuronium -sugammadex may be a safe option for the multiple sclerosis patients who have been followed for neuromuscular block, body temperature and depth of anesthesia.
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